Barclays PLC Innoviva, Inc. Transaction History

Barclays PLC

$377 Billion
Q3 2024

A detailed history of Barclays PLC transactions in Innoviva, Inc. stock. As of the latest transaction made, Barclays PLC holds 100,594 shares of INVA stock, worth $1.93 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

100,594

Previous 100,594 -0.0%

Holding current value

$1.93 Million

Previous $1.94 Million -0.0%

% of portfolio

0.0%

Previous 0.0%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 15, 2024	BUY	$16.33 - $20.04 $1.18 Million - $1.45 Million	72,192 Added 254.18%	100,594 $1.94 Million
Q2 2024 Aug 14, 2024	SELL	$14.4 - $16.4 $451,584 - $514,303	-31,360 Reduced 52.47%	28,402 $467,000
Q1 2024 May 15, 2024	SELL	$14.56 - $16.78 $653,831 - $753,522	-44,906 Reduced 42.9%	59,762 $910,000
Q4 2023 Feb 15, 2024	BUY	$12.32 - $16.27 $784,919 - $1.04 Million	63,711 Added 155.56%	104,668 $1.68 Million
Q3 2023 Nov 07, 2023	BUY	$12.37 - $13.89 $74,158 - $83,270	5,995 Added 17.15%	40,957 $531,000
Q2 2023 Aug 03, 2023	SELL	$11.39 - $13.72 $293,884 - $354,003	-25,802 Reduced 42.46%	34,962 $446,000
Q1 2023 May 04, 2023	BUY	$10.73 - $13.6 $8,079 - $10,240	753 Added 1.25%	60,764 $683,000
Q4 2022 Feb 13, 2023	SELL	$11.8 - $13.78 $83,225 - $97,190	-7,053 Reduced 10.52%	60,011 $795,000
Q3 2022 Nov 03, 2022	SELL	$11.61 - $15.22 $290,284 - $380,545	-25,003 Reduced 27.16%	67,064 $779,000
Q2 2022 Aug 12, 2022	BUY	$14.32 - $19.88 $208,957 - $290,088	14,592 Added 18.83%	92,067 $1.36 Million
Q1 2022 May 16, 2022	SELL	$15.39 - $20.25 $128,321 - $168,844	-8,338 Reduced 9.72%	77,475 $1.5 Million
Q4 2021 Feb 14, 2022	BUY	$15.91 - $18.72 $213,925 - $251,709	13,446 Added 18.58%	85,813 $1.48 Million
Q3 2021 Nov 09, 2021	BUY	$13.06 - $17.24 $247,134 - $326,232	18,923 Added 35.41%	72,367 $1.21 Million
Q2 2021 Aug 13, 2021	SELL	$11.45 - $13.96 $547,103 - $667,036	-47,782 Reduced 47.2%	53,444 $717,000
Q1 2021 May 13, 2021	SELL	$11.06 - $12.87 $239,249 - $278,403	-21,632 Reduced 17.61%	101,226 $1.21 Million
Q4 2020 Feb 11, 2021	SELL	$9.33 - $12.48 $20,581 - $27,530	-2,206 Reduced 1.76%	122,858 $1.52 Million
Q3 2020 Nov 12, 2020	BUY	$10.33 - $14.49 $189,855 - $266,311	18,379 Added 17.23%	125,064 $1.31 Million
Q2 2020 Aug 12, 2020	BUY	$11.49 - $15.26 $477,501 - $634,175	41,558 Added 63.81%	106,685 $1.49 Million
Q1 2020 May 13, 2020	SELL	$8.11 - $15.23 $279,032 - $524,003	-34,406 Reduced 34.57%	65,127 $767,000
Q4 2019 Feb 10, 2020	SELL	$10.28 - $14.38 $852,756 - $1.19 Million	-82,953 Reduced 45.46%	99,533 $1.41 Million
Q3 2019 Nov 14, 2019	BUY	$10.05 - $14.55 $709,138 - $1.03 Million	70,561 Added 63.04%	182,486 $1.92 Million
Q2 2019 Aug 14, 2019	BUY	$13.1 - $14.95 $87,508 - $99,866	6,680 Added 6.35%	111,925 $1.63 Million
Q1 2019 May 15, 2019	BUY	$13.69 - $20.06 $469,334 - $687,716	34,283 Added 48.31%	105,245 $1.48 Million
Q4 2018 Feb 14, 2019	SELL	$13.96 - $18.26 $319,753 - $418,245	-22,905 Reduced 24.4%	70,962 $1.24 Million
Q3 2018 Nov 14, 2018	BUY	$13.63 - $15.7 $383,561 - $441,813	28,141 Added 42.82%	93,867 $1.43 Million
Q2 2018 Aug 14, 2018	BUY	$13.44 - $17.59 $484,014 - $633,468	36,013 Added 121.2%	65,726 $907,000
Q1 2018 May 15, 2018	BUY	$13.8 - $16.99 $170,554 - $209,979	12,359 Added 71.22%	29,713 $496,000
Q4 2017 Feb 14, 2018	SELL	$11.73 - $14.75 $194,025 - $243,979	-16,541 Reduced 48.8%	17,354 $246,000
Q3 2017 Nov 14, 2017	BUY	$12.06 - $14.12 $408,773 - $478,597	33,895	33,895 $479,000

Others Institutions Holding INVA

# of Institutions

229

Shares Held

79.2M

Call Options Held

37.6K

Put Options Held

300

View Full List

About Innoviva, Inc.

Ticker INVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,706,000
Market Cap $1.33B
Description
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...

More about INVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account